Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS study

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Antó Josep M) > Body mass index and...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		09170naa a2200865 4500
001		oai:DiVA.org:umu-168520
003		SwePub
008		200302s2020 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
009		oai:DiVA.org:uu-414655
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1685202 URI
024	7	a https://doi.org/10.1136/thoraxjnl-2019-2138802 DOI
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4146552 URI
040		a (SwePub)umud (SwePub)uu
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Peralta, Gabriela P.u ISGlobal, Barcelona, Spain.;Univ Pompeu Fabra UPF, Barcelona, Spain.;CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.4 aut
245	1 0	a Body mass index and weight change are associated with adult lung function trajectories :b the prospective ECRHS study
264		c 2020-02-25
264	1	b BMJ Publishing Group Ltd,c 2020
338		a electronic2 rdacarrier
520		a BACKGROUND: Previous studies have reported an association between weight increase and excess lung function decline in young adults followed for short periods. We aimed to estimate lung function trajectories during adulthood from 20-year weight change profiles using data from the population-based European Community Respiratory Health Survey (ECRHS).METHODS: We included 3673 participants recruited at age 20-44 years with repeated measurements of weight and lung function (forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1)) in three study waves (1991-93, 1999-2003, 2010-14) until they were 39-67 years of age. We classified subjects into weight change profiles according to baseline body mass index (BMI) categories and weight change over 20 years. We estimated trajectories of lung function over time as a function of weight change profiles using population-averaged generalised estimating equations.RESULTS: In individuals with normal BMI, overweight and obesity at baseline, moderate (0.25-1 kg/year) and high weight gain (>1 kg/year) during follow-up were associated with accelerated FVC and FEV1 declines. Compared with participants with baseline normal BMI and stable weight (±0.25 kg/year), obese individuals with high weight gain during follow-up had -1011 mL (95% CI -1.259 to -763) lower estimated FVC at 65 years despite similar estimated FVC levels at 25 years. Obese individuals at baseline who lost weight (<-0.25 kg/year) exhibited an attenuation of FVC and FEV1 declines. We found no association between weight change profiles and FEV1/FVC decline.CONCLUSION: Moderate and high weight gain over 20 years was associated with accelerated lung function decline, while weight loss was related to its attenuation. Control of weight gain is important for maintaining good lung function in adult life.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Lungmedicin och allergi0 (SwePub)302192 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Respiratory Medicine and Allergy0 (SwePub)302192 hsv//eng
653		a BMI
653		a adults
653		a epidemiology
653		a lung function
653		a obesity
653		a weight change
700	1	a Marcon, Alessandrou Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy.4 aut
700	1	a Carsin, Anne-Elieu ISGlobal, Barcelona, Spain.;Univ Pompeu Fabra UPF, Barcelona, Spain.;CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.;IMIM Hosp del Mar Med Res Inst, Barcelona, Spain.4 aut
700	1	a Abramson, Michael J.u Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.4 aut
700	1	a Accordini, Simoneu Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy.4 aut
700	1	a Amaral, André F.S.u Imperial Coll London, Natl Heart & Lung Inst, London, England.4 aut
700	1	a Antó, Josep M.u ISGlobal, Barcelona, Spain.;Univ Pompeu Fabra UPF, Barcelona, Spain.;CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.4 aut
700	1	a Bowatte, Gayanu Univ Melbourne, Ctr Epidemiol & Biostat, Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Melbourne, Vic, Australia.;Natl Inst Fundamental Studies, Kandy, Sri Lanka.4 aut
700	1	a Burney, Peteru Imperial Coll London, Natl Heart & Lung Inst, London, England.4 aut
700	1	a Corsico, Angelou Univ Pavia, San Matteo Hosp Fdn, IRCCS, Div Resp Dis, Pavia, Italy.4 aut
700	1	a Demoly, Pascalu Univ Hosp Montpellier, Hop Arnaud Villeneuve, Dept Pneumol & Addictol, Montpellier, France.;Sorbonne Univ, UPMC, IPleSP, INSERM,UMr S 1136, Paris, France.4 aut
700	1	a Dharmage, Shyamaliu Univ Melbourne, Ctr Epidemiol & Biostat, Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Melbourne, Vic, Australia.4 aut
700	1	a Forsberg, Bertilu Umeå universitet,Avdelningen för hållbar hälsa,Umea Univ, Dept Publ Hlth & Clin Med, Sect Sustainable Hlth, Umea, Sweden.4 aut0 (Swepub:umu)befo0001
700	1	a Fuertes, Elaineu Imperial Coll London, Natl Heart & Lung Inst, London, England.4 aut
700	1	a Garcia-Larsen, Vanessau Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Human Nutr, Baltimore, MD USA.4 aut
700	1	a Gíslason, Thorarinnu Univ Hosp Reykjavik, Landspitali, Dept Sleep, Reykjavik, Iceland.;Univ Iceland, Fac Med, Reykjavik, Iceland.4 aut
700	1	a Gullón, José-Antoniou Hosp San Agustin, Dept Pneumol, Aviles, Spain.4 aut
700	1	a Heinrich, Joachimu Univ Melbourne, Ctr Epidemiol & Biostat, Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Melbourne, Vic, Australia.;Univ Hosp Munich LMU, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.;German Ctr Lung Res DZL, Comprehens Pneumol Ctr Munich CPC M, Munich, Germany.4 aut
700	1	a Holm, Mathiasu Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden.4 aut
700	1	a Jarvis, Deborah L.u Imperial Coll London, Natl Heart & Lung Inst, London, England.;Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England.4 aut
700	1	a Janson, Christeru Uppsala universitet,Lung- allergi- och sömnforskning4 aut0 (Swepub:uu)chrisjn
700	1	a Jogi, Rainu Tartu Univ Hosp, Lung Clin, Tartu, Estonia.4 aut
700	1	a Johannessen, Aneu Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.;Haukeland Hosp, Dept Occupat Med, Bergen, Norway.4 aut
700	1	a Leynaert, Bénédicteu VIMA Aging & Chron Dis Epidemiol & Publ Hlth Appr, INSERM U1168, Villejuif, France.;Univ Versailles St Quentin En Yvelines, UMR S 1168, St Quentin EnYvelines, France.4 aut
700	1	a Rovira, Jesús Martínez-Moratallau Univ Castilla La Mancha, Fac Med Albacete, Albacete, Spain.4 aut
700	1	a Nowak, Dennisu Univ Hosp Munich LMU, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.;German Ctr Lung Res DZL, Comprehens Pneumol Ctr Munich CPC M, Munich, Germany.4 aut
700	1	a Probst-Hensch, Nicoleu Swiss Trop & Publ Hlth Inst, Basel, Switzerland.;Univ Basel, Dept Publ Hlth, Basel, Switzerland.4 aut
700	1	a Raherison, Chantalu Bordeaux Univ, Inst Publ Hlth & Epidemiol, INSERM U897, Bordeaux, France.4 aut
700	1	a Sánchez-Ramos, José-Luisu Univ Huelva, Dept Nursing, Huelva, Spain.4 aut
700	1	a Sigsgaard, Torbenu Aarhus Univ, Sect Environm Occupat & Hlth, Danish Ramazzini Ctr, Dept Publ Hlth, Aarhus, Denmark.4 aut
700	1	a Siroux, Valérieu Team Environm Epidemiol Appl Reprod & Resp Hlth, UGA Inserm U1209 CNRS UMR 5309, Inst Adv Biosci, Grenoble, France.4 aut
700	1	a Squillacioti, Giuliau Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy.4 aut
700	1	a Urrutia, Isabelu Galdakao Hosp, Dept Resp, Galdakao, Spain.4 aut
700	1	a Weyler, Joostu Univ Antwerp, Dept Epidemiol & Social Med, Antwerp, Belgium.4 aut
700	1	a Zock, Jan-Paulu ISGlobal, Barcelona, Spain.;Univ Pompeu Fabra UPF, Barcelona, Spain.;CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.4 aut
700	1	a Garcia-Aymerich, Judithu ISGlobal, Barcelona, Spain.;Univ Pompeu Fabra UPF, Barcelona, Spain.;CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.4 aut
710	2	a ISGlobal, Barcelona, Spain.;Univ Pompeu Fabra UPF, Barcelona, Spain.;CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.b Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy.4 org
773	0	t Thoraxd : BMJ Publishing Group Ltdg 75:4, s. 313-320q 75:4<313-320x 0040-6376x 1468-3296
856	4	u https://doi.org/10.1136/thoraxjnl-2019-213880y Fulltext
856	4	u https://umu.diva-portal.org/smash/get/diva2:1410848/FULLTEXT02.pdfx primaryx Raw objecty fulltext:print
856	4	u https://thorax.bmj.com/content/thoraxjnl/75/4/313.full.pdf
856	4	u https://uu.diva-portal.org/smash/get/diva2:1447836/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-168520
856	4 8	u https://doi.org/10.1136/thoraxjnl-2019-213880
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-414655

Hitta via bibliotek

Thorax (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Lungmedicin och ...

Artiklar i publikationen: Thorax

Av lärosätet: Umeå universitet; Uppsala universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se